Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
EPS Diluted Over TimeStrong
Percentile Rank93
3Y CAGR+2.8%
5Y CAGR+6.3%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
+2.8%/yr
vs +15.8%/yr prior
5Y CAGR
+6.3%/yr
Recent deceleration
Acceleration
-13.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 41.48 | +8.2% |
| 2024 | 38.34 | +10.3% |
| 2023 | 34.77 | -9.0% |
| 2022 | 38.22 | -46.9% |
| 2021 | 71.97 | +135.8% |
| 2020 | 30.52 | +65.3% |
| 2019 | 18.46 | -13.3% |
| 2018 | 21.29 | +105.9% |
| 2017 | 10.34 | +34.3% |
| 2016 | 7.70 | - |